Published 3 months ago • loading... • Updated 3 months ago

Novartis to Exit Indian Unit With $159 Million Stake Sale

On February 20, 2026, Novartis AG agreed to sell its 70.68% stake in Novartis India Ltd. to a consortium of WaveRise Investments, ChrysCapital Fund X and Two Infinity Partners for 14.46 billion rupees.
Novartis said the two-year strategic review conveyed in February 2024 led to the divestment and a shift to a pure‑play innovative medicines strategy.
Shares of NIL jumped around 16% to ₹966.50 at 11.30 a.m., from a Thursday close of ₹830.45, after rising about 20%.
The deal triggered a mandatory open offer to acquire up to 26% of NIL at ₹860.84 per share, valuing that at about 5.52 billion rupees, and Novartis will cease control.
Novartis will continue operations in India through its wholly owned Novartis Healthcare Pvt. Ltd., which houses the Novartis Corporate Centre in Hyderabad and manages R&D teams conducting clinical trials at more than 300 sites.

Insights by Ground AI

12 Articles

Pharmaceutical Industry: Novartis Sells India Subsidiary – Share Increases Significantly

The Group wants to expand its business in the USA and withdraws from other markets. Novartis has now found a buyer for an Indian subsidiary.

3 months ago·Düsseldorf, Germany

Read Full Article

Globo

Lean Right

Novartis ad Exit From the Indian Branch with Sale of Participation

3 months ago·Brazil

Read Full Article

SWI swissinfo.ch

Lean Left

Novartis to Exit Indian Unit With $159 Million Stake Sale

(Bloomberg) -- Novartis AG has agreed to sell a majority stake in its listed Indian unit, marking the culmination of a strategic review announced two years ago.

3 months ago·Bern, Switzerland

Read Full Article

The Hindu

Lean Left

Novartis India shares zoom on Swiss parent’s ₹1,446 cr. exit plan

Novartis AG selling entire 70.68% in the Indian arm to WaveRise Investments, ChrysCapital Fund X and Two Infinity Partners, triggering mandatory open offer by the investor consortium to acquire 26% public shareholding

3 months ago·India

Read Full Article

Times of India

Reposted by

The Economic Times

Lean Right

Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore deal

Novartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A consortium of investors will acquire the stake at Rs 860.64 per share, a 3.6% premium. They've also launched an offer for an additional 26% from public shareholders.

3 months ago·India

Read Full Article